CHEN MILTON 4
4 · VSEE HEALTH, INC. · Filed Jun 2, 2026
Research Summary
AI-generated summary of this filing
VSee Health CEO Milton Chen Sells 2,870,069 Shares
What Happened
Milton Chen, CEO of VSee Health, disposed of 2,870,069 shares of VSee common stock on May 31, 2026. The shares were reported as transferred to the company at a price of $0.00, giving a reported transaction value of $0. According to the filing, the transfer was made pursuant to a Stock Purchase Agreement and served as consideration for Mr. Chen’s purchase of all equity securities of VSee Lab, Inc. from the company — i.e., this was a corporate exchange, not an open-market sale for cash.
Key Details
- Transaction date: May 31, 2026; Filing date: June 2, 2026 (reported within the required Form 4 window).
- Transaction: Disposition of 2,870,069 shares at $0.00; total reported value $0. (Transaction code J — “other acquisition or disposition”.)
- Shares owned after transaction: not specified in the Form 4 provided.
- Footnote: The transfer was made under a Stock Purchase Agreement in which Mr. Chen transferred these shares to the company as consideration for buying VSee Lab, Inc. equity from the company.
- Filing timeliness: Filed June 2, 2026 for a May 31 transaction — appears to meet the standard two-business-day reporting requirement.
Context
This was a non-market, corporate transaction (share transfer as part of an asset/equity purchase), so it’s different from an insider selling shares for personal liquidity. Such transfers can reflect deal structuring rather than a direct signal about the insider’s view of the company’s public-share value.
Insider Transaction Report
- Other
Common Stock, par value $0.0001 per share
[F1]2026-05-31−2,870,069→ 0 total
Footnotes (1)
- [F1]On May 31, 2026, in connection with the execution that certain Stock Purchase Agreement by and between VSee Health, Inc. ("Company") and Milton Chen ("Mr. Chen") (hereinafter, the "Agreement"), Mr. Chen agreed to transfer 2,870,069 shares of Common Stock to the Company, as consideration for Mr. Chen's purchase of all of the equity securities of VSee Lab, Inc., a Delaware corporation from the Company, in accordance with the terms of the Agreement.